Biomarkers of host response predict primary end-point radiological pneumonia in Tanzanian children with clinical pneumonia: A prospective cohort study

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Erdman, Laura K ^a   D'Acremont, Valérie ^b,c   Hayford, Kyla ^a   Rajwans, Nimerta ^a   Kilowoko, Mary ^d   Kyungu, Esther ^e   Hongoa, Philipina ^e   Alamo, Leonor ^f   Streiner, David L ^g   Genton, Blaise ^b,c,f   Kain, Kevin C ^a  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d Amana District Hospital   (Tanzania)

^e Ifakara Medical College   (Tanzania)

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHITINASE 3 LIKE 1; ENDOGLIN; PROCALCITONIN; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; ADIPOCYTOKINE; CALCA PROTEIN, HUMAN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CELL SURFACE RECEPTOR; CHI3L1 PROTEIN, HUMAN; CHITINASE 3 LIKE PROTEIN 1; ENG PROTEIN, HUMAN; LECTIN; LEUKOCYTE ANTIGEN; PROTEIN PRECURSOR;

ARTICLE; CHILD; COHORT ANALYSIS; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FEVER; HUMAN; INFANT; LUNG INFILTRATE; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TANZANIAN; THORAX RADIOGRAPHY; BLOOD; DIAGNOSTIC IMAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; PRESCHOOL CHILD; RADIOGRAPHY; REGRESSION ANALYSIS; STATISTICAL MODEL; TANZANIA;

ADIPOKINES; ANTIGENS, CD; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; CALCITONIN GENE-RELATED PEPTIDE; CHILD, PRESCHOOL; CHITINASE-3-LIKE PROTEIN 1; COHORT STUDIES; ENDOGLIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FEVER; HUMANS; INFANT; LECTINS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; PNEUMONIA; PROTEIN PRECURSORS; RADIOGRAPHY; RECEPTOR, TIE-2; RECEPTORS, CELL SURFACE; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TANZANIA; VON WILLEBRAND FACTOR;

EID: 84947440607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137592     Document Type: Article

References (48)

1. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379 (9832): 2151-61. doi: 10.1016/S0140-6736(12)60560-1 PMID: 22579125
2. Pittet LF, Posfay-Barbe KM. Pneumococcal vaccines for children: a global public health priority. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2012; 18 Suppl 5: 25-36.
3. Theodoratou E, Johnson S, Jhass A, Madhi SA, Clark A, Boschi-Pinto C, et al. The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality. International journal of epidemiology. 2010; 39 Suppl 1: i172-85. doi: 10.1093/ije/dyq033 PMID: 20348119
4. Murray J, Agocs M, Serhan F, Singh S, Deloria-Knoll M, O'Brien K, et al. Global invasive bacterial vaccine- preventable diseases surveillance-2008-2014. MMWR Morbidity and mortality weekly report. 2014; 63(49): 1159-62. PMID: 25503919
5. Vernatter J, Pirofski LA. Current concepts in host-microbe interaction leading to pneumococcal pneumonia. Curr Opin Infect Dis. 2013; 26(3): 277-83. doi: 10.1097/QCO.0b013e3283608419 PMID: 23571695
6. Woods CR. Acute bacterial pneumonia in childhood in the current era. Pediatr Ann. 2008; 37(10): 694-702. PMID: 18972852
7. Technical bases for the WHO recommendations on the management of pneumonia in children at firstlevel health facilites. Geneva: World Health Organization; 1991. Available: http://whqlibdoc.who.int/ hq/1991/WHO-ARI-91.20.pdf?ua=1.
8. Sazawal S, Black RE. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis. 2003; 3(9): 547-56. PMID: 12954560
9. Hazir T, Nisar YB, Qazi SA, Khan SF, Raza M, Zameer S, et al. Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by World Health Organization: descriptive multicentre study in Pakistan. BMJ. 2006; 333(7569): 629. PMID: 16923771
10. Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children. Geneva: World Health Organization Pneumonia Vaccine Trial Investigators' Group; 2001. Available: http://whqlibdoc.who.int/hq/2001/WHO-V&B-01.35.pdf.
11. Courtoy I, Lande AE, Turner RB. Accuracy of radiographic differentiation of bacterial from nonbacterial pneumonia. Clinical pediatrics. 1989; 28(6): 261-4. PMID: 2656052
12. Friis B, Eiken M, Hornsleth A, Jensen A. Chest X-ray appearances in pneumonia and bronchiolitis. Correlation to virological diagnosis and secretory bacterial findings. Acta paediatrica Scandinavica. 1990; 79(2): 219-25. PMID: 2321485
13. Virkki R, Juven T, Rikalainen H, Svedstrom E, Mertsola J, Ruuskanen O. Differentiation of bacterial and viral pneumonia in children. Thorax. 2002; 57(5): 438-41. PMID: 11978922
14. Esposito S, Tagliabue C, Picciolli I, Semino M, Sabatini C, Consolo S, et al. Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia. Respiratory medicine. 2011; 105(12): 1939-45. doi: 10.1016/j.rmed.2011.09.003 PMID: 21959024
15. Andronikou S, McHugh K, Abdurahman N, Khoury B, Mngomezulu V, Brant WE, et al. Paediatric radiology seen from Africa. Part I: providing diagnostic imaging to a young population. Pediatr Radiol. 2011; 41(7): 811-25. doi: 10.1007/s00247-011-2081-8 PMID: 21656276
16. Cherian T, Mulholland EK, Carlin JB, Ostensen H, Amin R, de Campo M, et al. Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies. Bull World Health Organ. 2005; 83(5): 353-9. PMID: 15976876
17. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, Okoko JB, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005; 365(9465): 1139-46. PMID: 15794968
18. Enwere G, Cheung YB, Zaman SM, Akano A, Oluwalana C, Brown O, et al. Epidemiology and clinical features of pneumonia according to radiographic findings in Gambian children. Trop Med Int Health. 2007; 12(11): 1377-85. PMID: 18045264
19. Wilkins TR, Wilkins RL. Clinical and radiographic evidence of pneumonia. Radiol Technol. 2005; 77(2): 106-10. PMID: 16335339
20. Rambaud-Althaus C, Althaus F, Genton B, D'Acremont V. Clinical features for diagnosis of pneumonia in children younger than 5 years: a systematic review and meta-analysis. Lancet Infect Dis. 2015; 15 (4): 439-50. doi: 10.1016/S1473-3099(15)70017-4 PMID: 25769269
21. Oved K, Cohen A, Boico O, Navon R, Friedman T, Etshtein L, et al. A Novel Host-Proteome Signature for Distinguishing between Acute Bacterial and Viral Infections. PLoS One. 2015; 10(3): e0120012. doi: 10.1371/journal.pone.0120012 PMID: 25785720
22. Zaas AK, Burke T, Chen M, McClain M, Nicholson B, Veldman T, et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Science translational medicine. 2013; 5(203): 203ra126. doi: 10.1126/scitranslmed.3006280 PMID: 24048524
23. van der Meer V, Neven AK, van den Broek PJ, Assendelft WJ. Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review. BMJ. 2005; 331(7507): 26. PMID: 15979984
24. Berg P, Lindhardt BO. The role of procalcitonin in adult patients with community-acquired pneumonia- a systematic review. Danish medical journal. 2012; 59(3): A4357. PMID: 22381083
25. Cheung YB, Zaman SM, Ruopuro ML, Enwere G, Adegbola RA, Greenwood B, et al. C-reactive protein and procalcitonin in the evaluation of the efficacy of a pneumococcal conjugate vaccine in Gambian children. Trop Med Int Health. 2008; 13(5): 603-11. doi: 10.1111/j.1365-3156.2008.02050.x PMID: 18331385
26. Madhi SA, Kohler M, Kuwanda L, Cutland C, Klugman KP. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J. 2006; 25(1): 30-6. PMID: 16395099
27. D'Acremont V, Kilowoko M, Kyungu E, Philipina S, Sangu W, Kahama-Maro J, et al. Beyond malaria- causes of fever in outpatient Tanzanian children. N Engl J Med. 2014; 370(9): 809-17. doi: 10.1056/ NEJMoa1214482 PMID: 24571753
28. Emergency Triage Assessment and Treatment (ETAT) course. Geneva: World Health Organization; 2005. Available: http://whqlibdoc.who.int/publications/2005/9241546875-eng.pdf.
29. Erdman LK, Dhabangi A, Musoke C, Conroy AL, Hawkes M, Higgins S, et al. Combinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control study. PLoS One. 2010; 6(2): e17440.
30. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982; 143(1): 29-36. PMID: 7063747
31. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons, Inc; 2000.
32. Perkins NJ, Schisterman EF. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006; 163(7): 670-5. PMID: 16410346
33. Breiman LF, J.H.; Olshen R.A.; Stone C. J. Classification and Regression Trees ( 2nd Ed.). Pacific Grove, CA: Wadsworth; 1984.
34. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W. Classification and regression tree analysis in public health: methodological review and comparison with logistic regression. Annals of behavioral medicine: a publication of the Society of Behavioral Medicine. 2003; 26(3): 172-81.
35. Huang H, Ideh RC, Gitau E, Thezenas ML, Jallow M, Ebruke B, et al. Discovery and validation of biomarkers to guide clinical management of pneumonia in African children. Clin Infect Dis. 2014; 58(12): 1707-15. doi: 10.1093/cid/ciu202 PMID: 24696240
36. Coffman FD. Chitinase 3-Like-1 (CHI3L1): a putative disease marker at the interface of proteomics and glycomics. Crit Rev Clin Lab Sci. 2008; 45(6): 531-62. doi: 10.1080/10408360802334743 PMID: 19003601
37. Nordenbaek C, Johansen JS, Junker P, Borregaard N, Sorensen O, Price PA. YKL-40, a matrix protein of specific granules in neutrophils, is elevated in serum of patients with community-acquired pneumonia requiring hospitalization. J Infect Dis. 1999; 180(5): 1722-6. PMID: 10515841
38. Dela Cruz CS, Liu W, He CH, Jacoby A, Gornitzky A, Ma B, et al. Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses. Cell Host Microbe. 2012; 12(1): 34-46. doi: 10.1016/j.chom.2012.05.017 PMID: 22817986
39. Collins PL, Graham BS. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol. 2008; 82(5): 2040-55. PMID: 17928346
40. Arnold R, Konig W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol. 2005; 174(11): 7359-67. PMID: 15905583
41. de Wit M, Fijneman RJ, Verheul HM, Meijer GA, Jimenez CR. Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications. Clin Biochem. 2013; 46(6): 466-79. doi: 10.1016/j.clinbiochem.2012.10.039 PMID: 23159294
42. Chan CP, Mak WC, Cheung KY, Sin KK, Yu CM, Rainer TH, et al. Evidence-based point-of-care diagnostics: current status and emerging technologies. Annu Rev Anal Chem (Palo Alto Calif). 2013; 6: 191-211.
43. Lynch T, Bialy L, Kellner JD, Osmond MH, Klassen TP, Durec T, et al. A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze. PLoS One. 2010; 5(8): e11989. doi: 10. 1371/journal.pone.0011989 PMID: 20700510
44. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011; 377(9773): 1264-75. doi: 10.1016/S0140-6736(10)61459-6 PMID: 21435708
45. Hazir T, Nisar YB, Abbasi S, Ashraf YP, Khurshid J, Tariq P, et al. Comparison of oral amoxicillin with placebo for the treatment of world health organization-defined nonsevere pneumonia in children aged 2-59 months: a multicenter, double-blind, randomized, placebo-controlled trial in pakistan. Clin Infect Dis. 2011; 52(3): 293-300. doi: 10.1093/cid/ciq142 PMID: 21189270
46. Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, et al. Effect of procalcitonin- based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. Jama. 2009; 302(10): 1059-66. doi: 10.1001/jama.2009.1297 PMID: 19738090
47. Baer G, Baumann P, Buettcher M, Heininger U, Berthet G, Schafer J, et al. Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial. PLoS One. 2013; 8(8): e68419. doi: 10.1371/journal.pone.0068419 PMID: 23936304
48. Diez-Padrisa N, Bassat Q, Machevo S, Quinto L, Morais L, Nhampossa T, et al. Procalcitonin and Creactive protein for invasive bacterial pneumonia diagnosis among children in Mozambique, a malariaendemic area. PLoS One. 2010; 5(10): e13226. doi: 10.1371/journal.pone.0013226 PMID: 20976241